Transcept Pharmaceuticals to Report Second Quarter 2013 Financial Results and
Host Conference Call on August 7, 2013
POINT RICHMOND, Calif., July 29, 2013
POINT RICHMOND, Calif., July 29, 2013 /PRNewswire/ --Transcept
Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company
focused on the development and commercialization of proprietary products that
address important therapeutic needs in the field of neuroscience, today
announced that the company will host a conference call on Wednesday, August 7,
2013, at 4:30 p.m. Eastern Time to discuss its second quarter 2013 financial
results. The conference call will follow the release of the Transcept second
quarter 2013 financial results after the close of market that day.
Conference Call Information
Date: Wednesday, August 7, 2013
Time: 4:30 p.m. ET
Dial-in (U.S.): (877) 638-4558
Dial-in (International): (914) 495-8537
A simultaneous webcast of the conference call will be available on the
Investors section of the Transcept website at www.transcept.com. A replay of
this webcast will be available on the website shortly after the conclusion of
the call and will be available through September 30, 2013.
Transcept Pharmaceuticals, Inc.is a specialty pharmaceutical company focused
on the development and commercialization of proprietary products that address
important therapeutic needs in the field of neuroscience. Intermezzo®
(zolpidem tartrate) sublingual tablet C-IV is the firstFDAapproved Transcept
product.PurduePharma holds commercialization and development rights for
Intermezzo in the United States. For further information about Transcept,
please visit www.transcept.com. For information about Intermezzo, please visit
Transcept Pharmaceuticals, Inc.
Vice President and Chief Financial Officer
SOURCE Transcept Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.